Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

ADMA Biologics

Tracked across 1 events · 55 articles · First seen Mar 26, 2026 · Last active Apr 17, 2026

Sentiment
-90
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 -90
Regulatory
ADMA Biologics is facing investigations for alleged securities fraud due to a channel stuffing scheme that purportedly inflated its 2025 revenue growth. This has led to a significant drop in its stock price and a downgrade from Cantor Fitzgerald.
Mar 26, 2026 · 55 articles
100 Bleichmar Fonti & Auld LLP initiated investigation into potential securities fraud ADMA BiologicsADMA Biologics Faces...
100 Culper Research published short report alleging channel stuffing ADMA BiologicsADMA Biologics Faces...
95 ADMA Biologics stock price declined 29%ADMA Biologics Faces...
95 ADMA Biologics stock price declined by 29%ADMA Biologics Faces...
95 Pomerantz LLP initiated investigation into securities fraud ADMA BiologicsADMA Biologics Faces...
95 Bleichmar Fonti & Auld LLP initiated investigation into securities fraud ADMA BiologicsADMA Biologics Faces...
90 ADMA Biologics allegedly engaged in channel stuffing to inflate revenueADMA Biologics Faces...
90 ADMA Biologics stock price fell 16.63%ADMA Biologics Faces...
+ 5 more actions View on Dashboard
Culper Research ADMA Biologics Unknown
NEWSDESK
Track ADMA Biologics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.